Related references
Note: Only part of the references are listed.A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Tau drives translational selectivity by interacting with ribosomal proteins
Shon A. Koren et al.
ACTA NEUROPATHOLOGICA (2019)
Distinct TrkA and Ret modulated negative and positive neuropathic behaviors in a mouse model of resiniferatoxin-induced small fiber neuropathy
Yu-Lin Hsieh et al.
EXPERIMENTAL NEUROLOGY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Review of the advances in treatment for Alzheimer disease: Strategies for combating beta-amyloid protein
J. Folch et al.
NEUROLOGIA (2018)
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
Joseph W. Arndt et al.
SCIENTIFIC REPORTS (2018)
Alzheimer's disease hypothesis and related therapies
Xiaoguang Du et al.
TRANSLATIONAL NEURODEGENERATION (2018)
Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism
Fawaz Alasmari et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
Mojtaba Golpich et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Targeting LRRK2 in Parkinson's disease: an update on recent developments
Sharon L. Chan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies
Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
Hibiki Kawamata et al.
JOURNAL OF CELL BIOLOGY (2017)
A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat
Yulia A. Sidorova et al.
FRONTIERS IN PHARMACOLOGY (2017)
Drug candidates in clinical trials for Alzheimer's disease
Shih-Ya Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Serotonergic Approaches in Parkinson's Disease: Translational Perspectives, an Update
Philippe Huot et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study
P. J. M. Urwin et al.
VOX SANGUINIS (2016)
MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function
Panchanan Maiti et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons
Hongtao Hu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
Jean-Marc Taymans et al.
CURRENT NEUROPHARMACOLOGY (2016)
Impaired Autophagy in APOE4 Astrocytes
Shira Simonovitch et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
Nicolas R. Barthelemy et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The clinical symptoms of Parkinson's disease
Sigurlaug Sveinbjornsdottir
JOURNAL OF NEUROCHEMISTRY (2016)
Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice
Ksenia V. Kastanenka et al.
JOURNAL OF NEUROSCIENCE (2016)
Current and novel therapeutic molecules and targets in Alzheimer's disease
Ashwini Kumar et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2016)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier et al.
LANCET (2016)
Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential
Y. A. Sidorova et al.
MOLECULAR BIOLOGY (2016)
NEURODEGENERATIVE DISEASES
Marie-Therese Heemels
NATURE (2016)
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain
Paul Alan Cox et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2016)
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
Veronika Logovinsky et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Differential Toxicity of Antibodies to the Prion Protein
Regina R. Reimann et al.
PLOS PATHOGENS (2016)
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Francesco Panza et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
Mark Ultsch et al.
SCIENTIFIC REPORTS (2016)
Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy
Yanjuan Hou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
Yvonne Bouter et al.
ACTA NEUROPATHOLOGICA (2015)
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease
Alan King Lun Liu et al.
ACTA NEUROPATHOLOGICA (2015)
Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
James P. Fuller et al.
ACTA NEUROPATHOLOGICA (2015)
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
Aashiq Hussain Bhat et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Clinical development of curcumin in neurodegenerative disease
Shuxin Hu et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay et al.
LANCET NEUROLOGY (2015)
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease
Eleonora Carboni et al.
METALLOMICS (2015)
Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity
Wei Xiang et al.
MOLECULAR NEURODEGENERATION (2015)
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Michael Lazarou et al.
NATURE (2015)
Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways
Annadurai Anandhan et al.
NEUROBIOLOGY OF DISEASE (2015)
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson's Disease
Alicia M. Pickrell et al.
NEURON (2015)
Clinical development of curcumin in neurodegenerative disease
Shuxin Hu et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
Sasanka Chakrabarti et al.
AGING AND DISEASE (2015)
Redox control of protein degradation
Marta Pajares et al.
REDOX BIOLOGY (2015)
Preconditioning as a Potential Strategy for the Prevention of Parkinson's Disease
Mojtaba Golpich et al.
MOLECULAR NEUROBIOLOGY (2015)
Molecular diagnostics of neurodegenerative disorders
Megha Agrawal et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
Anti-tau antibody reduces insoluble tau and decreases brain atrophy
Kiran Yanamandra et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors
Rosaria Gitto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Sex differences in mitochondrial biogenesis determine neuronal death and survival in response to oxygen glucose deprivation and reoxygenation
Jaswinder Sharma et al.
BMC NEUROSCIENCE (2014)
Adenosine A2A Receptor Antagonists in Parkinson's Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued
Annalisa Pinna
CNS DRUGS (2014)
USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin
Thomas M. Durcan et al.
EMBO JOURNAL (2014)
The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy
Tom Cornelissen et al.
HUMAN MOLECULAR GENETICS (2014)
Harnessing the Immune System for Treatment and Detection of Tau Pathology
Erin E. Congdon et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Adenosine A2A Receptor as a Drug Discovery Target
Manuel de Lera Ruiz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Glutamate as a neurotransmitter in the healthy brain
Y. Zhou et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
α-synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: Implications in the pathogenesis of Parkinson's disease
Aritri Bir et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis
Deborah Doens et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Combined Treatment with a BACE Inhibitor and Anti-Aβ Antibody Gantenerumab Enhances Amyloid Reduction in APPLondon Mice
Helmut Jacobsen et al.
JOURNAL OF NEUROSCIENCE (2014)
Prospects for Neuroprotective Therapies in Prodromal Huntington's Disease
Abhishek Chandra et al.
MOVEMENT DISORDERS (2014)
The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy
Baris Bingol et al.
NATURE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treating small fiber neuropathy by topical application of a small molecule modulator of ligand-induced GFRα/RET receptor signaling
Kristian L. Hedstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular chaperones and proteostasis regulation during redox imbalance
Katerina Niforou et al.
REDOX BIOLOGY (2014)
Alpha-Synuclein Function and Dysfunction on Cellular Membranes
David Snead et al.
Experimental Neurobiology (2014)
Development of M1 mAChR Allosteric and Bitopic Ligands: Prospective Therapeutics for the Treatment of Cognitive Deficits
Briana J. Davie et al.
ACS CHEMICAL NEUROSCIENCE (2013)
γ-Secretase inhibitors and modulators
Todd E. Golde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Sirtuin deacetylases in neurodegenerative diseases of aging
Adrianna Z. Herskovits et al.
CELL RESEARCH (2013)
Molecular Modeling of a Phenyl-Amidine Class of NMDA Receptor Antagonists and the Rational Design of New Triazolyl-Amidine Derivatives
Paula A. Abreu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease
Bruce J. Melancon et al.
DRUG DISCOVERY TODAY (2013)
ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice
Ori Liraz et al.
MOLECULAR NEURODEGENERATION (2013)
PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases
Mathea Pietri et al.
NATURE MEDICINE (2013)
Alzheimer disease therapy-moving from amyloid-β to tau
Ezio Giacobini et al.
NATURE REVIEWS NEUROLOGY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
Chris G. Parsons et al.
NEUROTOXICITY RESEARCH (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys
Maria Gabriela Sanchez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Mitochondrial Biogenesis through Activation of Nuclear Signaling Proteins
John E. Dominy et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Infectious particles, stress, and induced prion amyloids: A unifying perspective
Laura Manuelidis
VIRULENCE (2013)
Sirtuins in neurodegenerative diseases: an update on potential mechanisms
Sang-Won Min et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other
Darius Ebrahimi-Fakhari et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
Vladimir Coric et al.
ARCHIVES OF NEUROLOGY (2012)
Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease
Kuldeep K. Roy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
1-Benzyl-1,2,3,4-Tetrahydro-ß-Carboline as Channel Blocker of N-Methyl-d-Aspartate Receptors
Marlene Espinoza-Moraga et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies
Vittoria Colotta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of a novel amyloid precursor protein processing pathway that generates secreted N-terminal fragments
Laura J. Vella et al.
FASEB JOURNAL (2012)
Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
Bernd Bohrmann et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
Najla Kfoury et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
?-Secretase inhibitors and modulators for Alzheimer's disease
Michael S. Wolfe
JOURNAL OF NEUROCHEMISTRY (2012)
An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ
Oskar Adolfsson et al.
JOURNAL OF NEUROSCIENCE (2012)
NADPH Oxidase 1 Mediates α-Synucleinopathy in Parkinson's Disease
Ana Clara Cristovao et al.
JOURNAL OF NEUROSCIENCE (2012)
TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells
Daniel P. Fitzgerald et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Bengt Winblad et al.
LANCET NEUROLOGY (2012)
Glucose Regulated Protein 78 Diminishes α-Synuclein Neurotoxicity in a Rat Model of Parkinson Disease
Marina S. Gorbatyuk et al.
MOLECULAR THERAPY (2012)
The sirtuin SIRT6 regulates lifespan in male mice
Yariv Kanfi et al.
NATURE (2012)
α-Synuclein expression is modulated at the translational level by iron
Fabia Febbraro et al.
NEUROREPORT (2012)
The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax
Bethann N. Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?
David Protter et al.
PARKINSONS DISEASE (2012)
Mitochondrial Dysfunction in Neurodegenerative Diseases
Ashu Johri et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
ACS Chemical Neuroscience Molecule Spotlight on ELND006: Another γ-Secretase Inhibitor Fails in the Clinic
Corey R. Hopkins
ACS CHEMICAL NEUROSCIENCE (2011)
Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease
Sirsendu Jana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
Richard C. Scarpulla
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
G37R SOD1 mutant alters mitochondrial complex I activity, Ca2+ uptake and ATP production
Evelyne Coussee et al.
CELL CALCIUM (2011)
EHT0202 in Alzheimer's Disease: A 3-Month, Randomized, Placebo-Controlled, Double-Blind Study
B. Vellas et al.
CURRENT ALZHEIMER RESEARCH (2011)
Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis
Domenico Bosco et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid-β Immunotherapy
Allan Wang et al.
JOURNAL OF NEUROSCIENCE (2011)
Distinct Roles In Vivo for the Ubiquitin-Proteasome System and the Autophagy-Lysosomal Pathway in the Degradation of α-Synuclein
Darius Ebrahimi-Fakhari et al.
JOURNAL OF NEUROSCIENCE (2011)
Oxidative Stress-Mediated Regulation of Proteasome Complexes
Charity T. Aiken et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
DRUGS A tangled web of targets
Lauren Gravitz
NATURE (2011)
Molecular chaperones in protein folding and proteostasis
F. Ulrich Hartl et al.
NATURE (2011)
Mechanisms of mitophagy
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Serotonin-dependent depression in Parkinson's disease: A role for the subthalamic nucleus?
Sonny K. H. Tan et al.
NEUROPHARMACOLOGY (2011)
Age- and duration-dependent effects of MPTP on cortical serotonin systems
Twurn A. Ansah et al.
NEUROSCIENCE LETTERS (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Inhibition of α-synuclein aggregation by small heat shock proteins
Ilona B. Bruinsma et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Regulation of neuron mitochondrial biogenesis and relevance to brain health
Isaac G. Onyango et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Mitochondria: A therapeutic target in neurodegeneration
Paula I. Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis
M. R. D'Andrea et al.
BIOTECHNIC & HISTOCHEMISTRY (2010)
Curcumin and Alzheimer's Disease
Tsuyoshi Hamaguchi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
α-Synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: Implications in Parkinson's disease
Kalpita Banerjee et al.
FEBS LETTERS (2010)
Mitochondria-Targeted Antioxidants Protect Against Amyloid-beta Toxicity in Alzheimer's Disease Neurons
Maria Manczak et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future
Anthony E. Lang
NATURE MEDICINE (2010)
An Overview of APP Processing Enzymes and Products
Vivian W. Chow et al.
NEUROMOLECULAR MEDICINE (2010)
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models
Janet van Eersel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
γ-Secretase-Dependent Cleavage Initiates Notch Signaling from the Plasma Membrane
Erika B. Sorensen et al.
TRAFFIC (2010)
Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?
Marwan N. Sabbagh
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2009)
Mitochondria Targeted Peptides Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity
Lichuan Yang et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Conformational Changes Specific for Pseudophosphorylation at Serine 262 Selectively Impair Binding of Tau to Microtubules
Daniela Fischer et al.
BIOCHEMISTRY (2009)
Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors
Rong Sheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies
Mahmud Tareq Hassan Khan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial
Robert C. Green et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease
Paula I. Moreira et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Mitochondria, cholesterol and amyloid β peptide: a dangerous trio in Alzheimer disease
Anna Colell et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease
Teresa G. Hastings
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
Regulation of Prion Gene Expression by Transcription Factors SP1 and Metal Transcription Factor-1
Shayne A. Bellingham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Comparative virtual screening and novelty detection for NMDA-GlycineB antagonists
Bjoern A. Krueger et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Microinjection of lentiviral vectors expressing small interfering RNAs directed against laminin receptor precursor mRNA prolongs the pre-clinical phase in scrapie-infected mice
Heike Pflanz et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Xinglong Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev et al.
NATURE (2009)
Modulation of α-Synuclein Aggregation by Dopamine: A Review
Su Ling Leong et al.
NEUROCHEMICAL RESEARCH (2009)
RAPAMYCIN PROTECTS AGAINST ROTENONE-INDUCED APOPTOSIS THROUGH AUTOPHAGY INDUCTION
T. Pan et al.
NEUROSCIENCE (2009)
Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells
Matthew E. Gegg et al.
PLOS ONE (2009)
Therapy for prion diseases Insights from the use of RNA interference
Melanie D. White et al.
PRION (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease
Simone Engelender
AUTOPHAGY (2008)
Interactions between Hsp70 and the Hydrophobic Core of α-Synuclein Inhibit Fibril Assembly
Kelvin C. Luk et al.
BIOCHEMISTRY (2008)
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile
Rosaria Gitto et al.
CHEMMEDCHEM (2008)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease
Marcus W. Brazier et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Richard I. Morimoto
GENES & DEVELOPMENT (2008)
Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia
Huafeng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Parkin mitochondria in the autophagosome
Heidi M. McBride
JOURNAL OF CELL BIOLOGY (2008)
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Derek Narendra et al.
JOURNAL OF CELL BIOLOGY (2008)
Genes contributing to prion pathogenesis
Gultekin Tamguney et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing
M. Marcade et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons
Phullara B. Shelat et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
K. Haugarvoll et al.
NEUROLOGY (2008)
Transcriptional paradigms in mammalian mitochondrial biogenesis and function
Richard C. Scarpulla
PHYSIOLOGICAL REVIEWS (2008)
Rapidly Increased Neuronal Mitochondrial Biogenesis After Hypoxic-Ischemic Brain Injury
Wei Yin et al.
STROKE (2008)
Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease
Mahmoud Kiaei
PPAR RESEARCH (2008)
The redox chemistry of the Alzheimer's disease amyloid β peptide
Danielle G. Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
Tiago Fleming Outeiro et al.
SCIENCE (2007)
Brain serotonin transporter binding in non-depressed patients with Parkinson's disease
M. Guttman et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36
Sunghee Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
GDNF family receptor complexes are emerging drug targets
Maxim M. Bespalov et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice
Alexander Pfeifer et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Bace1 modulates myelination in the central and peripheral nervous system
Xiangyou Hu et al.
NATURE NEUROSCIENCE (2006)
Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease
M. Freixes et al.
NEUROBIOLOGY OF AGING (2006)
A key role for the microglial NADPH oxidase in APP-dependent killing of neurons
Bin Qin et al.
NEUROBIOLOGY OF AGING (2006)
Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1α transcription and mitochondrial biogenesis in muscle cells
Zhidan Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes
Sabine Gauczynski et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction
Latha Devi et al.
JOURNAL OF NEUROSCIENCE (2006)
Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis
Susanne Petri et al.
JOURNAL OF NEUROCHEMISTRY (2006)
A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3) K-Akt signalling
Lara Fallon et al.
NATURE CELL BIOLOGY (2006)
Suppression of prion protein in livestock by RNA interference
MC Golding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Interface between tauopathies and synucleinopathies: A tale of two proteins
WR Galpern et al.
ANNALS OF NEUROLOGY (2006)
Risk factors for variant Creutzfeldt-Jakob disease: A case-control study
HJT Ward et al.
ANNALS OF NEUROLOGY (2006)
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation
F Liu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice
D Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Redox metals and oxidative abnormalities in human prion diseases
RB Petersen et al.
ACTA NEUROPATHOLOGICA (2005)
Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation
CA Rankin et al.
MOLECULAR BRAIN RESEARCH (2005)
β subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase
HK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor
JT Slevin et al.
JOURNAL OF NEUROSURGERY (2005)
Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption
DY He et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Modulation of neurodegeneration by molecular chaperones
PJ Muchowski et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation
H Kadowaki et al.
CELL DEATH AND DIFFERENTIATION (2005)
HSP27 but not HSP70 has a potent protective effect against α-synuclein-induced cell death in mammalian neuronal cells
A Zourlidou et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Knock-down of the 37-kDa/67-kDa laminin receptor in mouse brain by transgenic expression of specific antisense LRP RNA
C Leucht et al.
TRANSGENIC RESEARCH (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
AH Peden et al.
LANCET (2004)
An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model
M Hashimoto et al.
GENE THERAPY (2004)
How does parkin ligate ubiquitin to Parkinson's disease? First in molecular medicine review series
PJ Kahle et al.
EMBO REPORTS (2004)
Hsp70 reduces α-synuclein aggregation and toxicity
J Klucken et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The importance of neuritic plaques and tangles to the development and evolution of AD
P Tiraboschi et al.
NEUROLOGY (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Scrapie-Infected Mice and PrP Knockout Mice Share Abnormal Localization and Activity of Neuronal Nitric Oxide Synthase
Gilmor I. Keshet et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Adenosine A2A receptor antagonist treatment of Parkinson's disease
W Bara-Jimenez et al.
NEUROLOGY (2003)
Efficient and specific down-regulation of prion protein expression by RNAi
G Tilly et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies
T Ishizawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Tremor in Parkinson's disease and serotonergic dysfunction -: An 11C-WAY 100635 PET study
M Doder et al.
NEUROLOGY (2003)
Acquired prion disease: iatrogenic CJD, variant CJD, kuru
RG Will
BRITISH MEDICAL BULLETIN (2003)
XIB4035, a novel nonpeptidyl small molecule agonist for GFR alpha-1
K Tokugawa et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species
LY Qin et al.
JOURNAL OF NEUROCHEMISTRY (2002)
TorsinA and heat shock proteins act as molecular chaperones:: suppression of α-synuclein aggregation
PJ McLean et al.
JOURNAL OF NEUROCHEMISTRY (2002)
A pilot study of the manual force levels required to produce manipulation induced hypoalgesia
S McLean et al.
CLINICAL BIOMECHANICS (2002)
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
JC Dodart et al.
NATURE NEUROSCIENCE (2002)
Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease
PK Auluck et al.
SCIENCE (2002)
CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils
IS Coraci et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease
JF Chen et al.
JOURNAL OF NEUROSCIENCE (2001)
The molecular biology of prion propagation
AR Clarke et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2001)
Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation
A Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
H Shimura et al.
NATURE GENETICS (2000)
Neuroprotection, excitotoxicity and NMDA antagonists
RJ Gagliardi
ARQUIVOS DE NEURO-PSIQUIATRIA (2000)
Share Paper
